 | • レポートコード：GIR-105X14220 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子組換え型タンパク質ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組換え型タンパク質ワクチンの種類別市場規模（細菌細胞培養、哺乳類細胞培養）、用途別市場規模（人間、動物）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組換え型タンパク質ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences、Novavax、Medicago ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：細菌細胞培養、哺乳類細胞培養 ・用途別分析2016年-2026年：人間、動物 ・遺伝子組換え型タンパク質ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組換え型タンパク質ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組換え型タンパク質ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組換え型タンパク質ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組換え型タンパク質ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Protein Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Protein Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Recombinant Protein Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Protein Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bacterial Cells Culture
Mammalian Cells Culture
Market segment by Application can be divided into
Human
Animal
The key market players for global Recombinant Protein Vaccine market are listed below:
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Novavax
Medicago
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Recombinant Protein Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Protein Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Bacterial Cells Culture
1.2.3 Mammalian Cells Culture
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Protein Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Human
1.3.3 Animal
1.4 Global Recombinant Protein Vaccine Market Size & Forecast
1.4.1 Global Recombinant Protein Vaccine Sales in Value (2016-2026))
1.4.2 Global Recombinant Protein Vaccine Sales in Volume (2016-2026)
1.4.3 Global Recombinant Protein Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Recombinant Protein Vaccine Production Capacity Analysis
1.5.1 Global Recombinant Protein Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Protein Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Protein Vaccine Market Drivers
1.6.2 Recombinant Protein Vaccine Market Restraints
1.6.3 Recombinant Protein Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Recombinant Protein Vaccine Product and Services
2.1.4 Merck Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Recombinant Protein Vaccine Product and Services
2.2.4 GSK Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Recombinant Protein Vaccine Product and Services
2.3.4 Sanofi Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Zoties
2.4.1 Zoties Details
2.4.2 Zoties Major Business
2.4.3 Zoties Recombinant Protein Vaccine Product and Services
2.4.4 Zoties Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Elanco
2.5.1 Elanco Details
2.5.2 Elanco Major Business
2.5.3 Elanco Recombinant Protein Vaccine Product and Services
2.5.4 Elanco Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Boehringer-Ingelheim
2.6.1 Boehringer-Ingelheim Details
2.6.2 Boehringer-Ingelheim Major Business
2.6.3 Boehringer-Ingelheim Recombinant Protein Vaccine Product and Services
2.6.4 Boehringer-Ingelheim Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Indian Immunologicals
2.7.1 Indian Immunologicals Details
2.7.2 Indian Immunologicals Major Business
2.7.3 Indian Immunologicals Recombinant Protein Vaccine Product and Services
2.7.4 Indian Immunologicals Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Plumbline Life Sciences
2.8.1 Plumbline Life Sciences Details
2.8.2 Plumbline Life Sciences Major Business
2.8.3 Plumbline Life Sciences Recombinant Protein Vaccine Product and Services
2.8.4 Plumbline Life Sciences Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Novavax
2.9.1 Novavax Details
2.9.2 Novavax Major Business
2.9.3 Novavax Recombinant Protein Vaccine Product and Services
2.9.4 Novavax Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Medicago
2.10.1 Medicago Details
2.10.2 Medicago Major Business
2.10.3 Medicago Recombinant Protein Vaccine Product and Services
2.10.4 Medicago Recombinant Protein Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Recombinant Protein Vaccine Sales by Manufacturer
3.1 Global Recombinant Protein Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Protein Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Protein Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Protein Vaccine Manufacturer Market Share
3.4.2 Top 6 Recombinant Protein Vaccine Manufacturer Market Share
3.5 Global Recombinant Protein Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Protein Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Protein Vaccine Market Size by Region
4.1.1 Global Recombinant Protein Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Protein Vaccine Revenue by Region (2016-2026)
4.2 North America Recombinant Protein Vaccine Revenue (2016-2026)
4.3 Europe Recombinant Protein Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Protein Vaccine Revenue (2016-2026)
4.5 South America Recombinant Protein Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Protein Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Protein Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Protein Vaccine Revenue by Type (2016-2026)
5.3 Global Recombinant Protein Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Protein Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Protein Vaccine Revenue by Application (2016-2026)
6.3 Global Recombinant Protein Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Protein Vaccine Sales by Type (2016-2026)
7.2 North America Recombinant Protein Vaccine Sales by Application (2016-2026)
7.3 North America Recombinant Protein Vaccine Market Size by Country
7.3.1 North America Recombinant Protein Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Protein Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Protein Vaccine Sales by Type (2016-2026)
8.2 Europe Recombinant Protein Vaccine Sales by Application (2016-2026)
8.3 Europe Recombinant Protein Vaccine Market Size by Country
8.3.1 Europe Recombinant Protein Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Protein Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Protein Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Protein Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Protein Vaccine Market Size by Region
9.3.1 Asia-Pacific Recombinant Protein Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Protein Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Protein Vaccine Sales by Type (2016-2026)
10.2 South America Recombinant Protein Vaccine Sales by Application (2016-2026)
10.3 South America Recombinant Protein Vaccine Market Size by Country
10.3.1 South America Recombinant Protein Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Protein Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Protein Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Protein Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Protein Vaccine Market Size by Country
11.3.1 Middle East & Africa Recombinant Protein Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Protein Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Protein Vaccine Typical Distributors
12.3 Recombinant Protein Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Recombinant Protein Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Protein Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Recombinant Protein Vaccine Product and Services
Table 6. Merck Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Recombinant Protein Vaccine Product and Services
Table 10. GSK Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Recombinant Protein Vaccine Product and Services
Table 14. Sanofi Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Zoties Basic Information, Manufacturing Base and Competitors
Table 16. Zoties Major Business
Table 17. Zoties Recombinant Protein Vaccine Product and Services
Table 18. Zoties Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Elanco Basic Information, Manufacturing Base and Competitors
Table 20. Elanco Major Business
Table 21. Elanco Recombinant Protein Vaccine Product and Services
Table 22. Elanco Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 24. Boehringer-Ingelheim Major Business
Table 25. Boehringer-Ingelheim Recombinant Protein Vaccine Product and Services
Table 26. Boehringer-Ingelheim Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 28. Indian Immunologicals Major Business
Table 29. Indian Immunologicals Recombinant Protein Vaccine Product and Services
Table 30. Indian Immunologicals Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Plumbline Life Sciences Basic Information, Manufacturing Base and Competitors
Table 32. Plumbline Life Sciences Major Business
Table 33. Plumbline Life Sciences Recombinant Protein Vaccine Product and Services
Table 34. Plumbline Life Sciences Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Novavax Basic Information, Manufacturing Base and Competitors
Table 36. Novavax Major Business
Table 37. Novavax Recombinant Protein Vaccine Product and Services
Table 38. Novavax Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Medicago Basic Information, Manufacturing Base and Competitors
Table 40. Medicago Major Business
Table 41. Medicago Recombinant Protein Vaccine Product and Services
Table 42. Medicago Recombinant Protein Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Recombinant Protein Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Recombinant Protein Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Recombinant Protein Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Recombinant Protein Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Recombinant Protein Vaccine Production Site of Key Manufacturer
Table 48. Global Recombinant Protein Vaccine Sales by Region (2016-2021e) & (K Units)
Table 49. Global Recombinant Protein Vaccine Sales by Region (2021-2026) & (K Units)
Table 50. Global Recombinant Protein Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Recombinant Protein Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Recombinant Protein Vaccine Sales by Type (2016-2021e) & (K Units)
Table 53. Global Recombinant Protein Vaccine Sales by Type (2021-2026) & (K Units)
Table 54. Global Recombinant Protein Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Recombinant Protein Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Recombinant Protein Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Recombinant Protein Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Recombinant Protein Vaccine Sales by Application (2016-2021e) & (K Units)
Table 59. Global Recombinant Protein Vaccine Sales by Application (2021-2026) & (K Units)
Table 60. Global Recombinant Protein Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Recombinant Protein Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Recombinant Protein Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Recombinant Protein Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Recombinant Protein Vaccine Sales by Country (2016-2021e) & (K Units)
Table 65. North America Recombinant Protein Vaccine Sales by Country (2021-2026) & (K Units)
Table 66. North America Recombinant Protein Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Recombinant Protein Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Recombinant Protein Vaccine Sales by Type (2016-2021e) & (K Units)
Table 69. North America Recombinant Protein Vaccine Sales by Type (2021-2026) & (K Units)
Table 70. North America Recombinant Protein Vaccine Sales by Application (2016-2021e) & (K Units)
Table 71. North America Recombinant Protein Vaccine Sales by Application (2021-2026) & (K Units)
Table 72. Europe Recombinant Protein Vaccine Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Recombinant Protein Vaccine Sales by Country (2021-2026) & (K Units)
Table 74. Europe Recombinant Protein Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Recombinant Protein Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Recombinant Protein Vaccine Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Recombinant Protein Vaccine Sales by Type (2021-2026) & (K Units)
Table 78. Europe Recombinant Protein Vaccine Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Recombinant Protein Vaccine Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Recombinant Protein Vaccine Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Recombinant Protein Vaccine Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Recombinant Protein Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Recombinant Protein Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Recombinant Protein Vaccine Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Recombinant Protein Vaccine Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Recombinant Protein Vaccine Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Recombinant Protein Vaccine Sales by Application (2021-2026) & (K Units)
Table 88. South America Recombinant Protein Vaccine Sales by Country (2016-2021e) & (K Units)
Table 89. South America Recombinant Protein Vaccine Sales by Country (2021-2026) & (K Units)
Table 90. South America Recombinant Protein Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Recombinant Protein Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Recombinant Protein Vaccine Sales by Type (2016-2021e) & (K Units)
Table 93. South America Recombinant Protein Vaccine Sales by Type (2021-2026) & (K Units)
Table 94. South America Recombinant Protein Vaccine Sales by Application (2016-2021e) & (K Units)
Table 95. South America Recombinant Protein Vaccine Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Recombinant Protein Vaccine Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Recombinant Protein Vaccine Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Recombinant Protein Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Recombinant Protein Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Recombinant Protein Vaccine Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Recombinant Protein Vaccine Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Recombinant Protein Vaccine Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Recombinant Protein Vaccine Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Recombinant Protein Vaccine Typical Distributors
Table 107. Recombinant Protein Vaccine Typical Customers
List of Figures
Figure 1. Recombinant Protein Vaccine Picture
Figure 2. Global Recombinant Protein Vaccine Sales Market Share by Type in 2020
Figure 3. Bacterial Cells Culture
Figure 4. Mammalian Cells Culture
Figure 5. Global Recombinant Protein Vaccine Sales Market Share by Application in 2020
Figure 6. Human
Figure 7. Animal
Figure 8. Global Recombinant Protein Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Recombinant Protein Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Recombinant Protein Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Recombinant Protein Vaccine Sales (2016-2026) & (K Units)
Figure 30. Global Recombinant Protein Vaccine Production Capacity (2016-2026) & (K Units)
Figure 31. Global Recombinant Protein Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Recombinant Protein Vaccine Market Drivers
Figure 33. Recombinant Protein Vaccine Market Restraints
Figure 34. Recombinant Protein Vaccine Market Trends
Figure 35. Global Recombinant Protein Vaccine Sales Market Share by Manufacturer in 2020
Figure 36. Global Recombinant Protein Vaccine Revenue Market Share by Manufacturer in 2020
Figure 37. Recombinant Protein Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Recombinant Protein Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Recombinant Protein Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Recombinant Protein Vaccine Sales Market Share by Region (2016-2026)
Figure 41. Global Recombinant Protein Vaccine Revenue Market Share by Region (2016-2026)
Figure 42. North America Recombinant Protein Vaccine Revenue (2016-2026) & (USD Million)
Figure 43. Europe Recombinant Protein Vaccine Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Recombinant Protein Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. South America Recombinant Protein Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Recombinant Protein Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Global Recombinant Protein Vaccine Sales Market Share by Type (2016-2026)
Figure 48. Global Recombinant Protein Vaccine Revenue Market Share by Type (2016-2026)
Figure 49. Global Recombinant Protein Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Recombinant Protein Vaccine Sales Market Share by Application (2016-2026)
Figure 51. Global Recombinant Protein Vaccine Revenue Market Share by Application (2016-2026)
Figure 52. Global Recombinant Protein Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Recombinant Protein Vaccine Sales Market Share by Country (2016-2026)
Figure 54. North America Recombinant Protein Vaccine Revenue Market Share by Country (2016-2026)
Figure 55. North America Recombinant Protein Vaccine Sales Market Share by Type (2016-2026)
Figure 56. North America Recombinant Protein Vaccine Sales Market Share by Application (2016-2026)
Figure 57. Europe Recombinant Protein Vaccine Sales Market Share by Country (2016-2026)
Figure 58. Europe Recombinant Protein Vaccine Revenue Market Share by Country (2016-2026)
Figure 59. Europe Recombinant Protein Vaccine Sales Market Share by Type (2016-2026)
Figure 60. Europe Recombinant Protein Vaccine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Recombinant Protein Vaccine Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Recombinant Protein Vaccine Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Recombinant Protein Vaccine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Recombinant Protein Vaccine Sales Market Share by Application (2016-2026)
Figure 65. South America Recombinant Protein Vaccine Sales Market Share by Country (2016-2026)
Figure 66. South America Recombinant Protein Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. South America Recombinant Protein Vaccine Sales Market Share by Type (2016-2026)
Figure 68. South America Recombinant Protein Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Recombinant Protein Vaccine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Recombinant Protein Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Recombinant Protein Vaccine Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Recombinant Protein Vaccine Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …- 世界の遺伝子組換え型血漿タンパク質治療薬市場 2021：企業別、地域別、種類・用途別 The Recombinant Plasma Protein Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 組換えハムスター卵巣細胞（CHO）B型肝炎ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chin…
- 世界の遺伝子組換え型B型肝炎ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- ヒトのワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administ…